Calcitriol Solution
NDC Package 70954-831-10
Package Information
Calcitriol solution is predialysis PatientsCalcitriol is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. This formulation utilizes a solution delivery system. Marketed by Ani Pharmaceuticals, Inc., this product is identified by NDC 70954-831 and is authorized under FDA application NDA021068.
Identification & Billing
- RxCUI: 313932 - calcitriol 1 MCG in 1 mL Oral Solution
- RxCUI: 313932 - calcitriol 0.001 MG/ML Oral Solution
- RxCUI: 313932 - calcitriol 1 MCG per 1 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70954 - Ani Pharmaceuticals, Inc.
- 70954-831 - Calcitriol
- 70954-831-10 - 1 BOTTLE, GLASS in 1 CARTON / 15 mL in 1 BOTTLE, GLASS
- 70954-831 - Calcitriol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70954-831-10 identifies a specific commercial package of 1 bottle, glass in 1 carton / 15 ml in 1 bottle, glass of Calcitriol, a human prescription drug labeled by Ani Pharmaceuticals, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 15 billable units per package. This solution is formulated for oral use and contains calcitriol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ani Pharmaceuticals, Inc. on May 13, 2026. The current certification is valid through December 31, 2027.
How is this Ani Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70954083110. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 15 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.